Use of Intralesional Sodium Thiosulfate for Treating Recurrent Calciphylaxis
Kazuki Ueno, Satsuki Tachibana, Yoshitaka Wada, Yoshifumi Iwahashi, Shin‐ichi Murata, Shinichi Asamura
Abstract
Open-access reader
Kazuki Ueno, Satsuki Tachibana, Yoshitaka Wada, Yoshifumi Iwahashi, Shin‐ichi Murata, Shinichi Asamura
Abstract
Open-access reader
Calciphylaxis is a rare and life-threatening disorder characterized by painful skin ulceration. Intravenous sodium thiosulfate has proven effective for calciphylaxis treatment; however, its use is associated with risk of complications, potentially necessitating hospitalization. Herein, we describe the case of a patient with calciphylaxis who experienced recurrence approximately 5 months after healing with a combination therapy of intralesional/intravenous sodium thiosulfate. We successfully treated the recurrent ulcers in outpatient care with intralesional sodium thiosulfate, which reportedly has few side effects. Although intravenous sodium thiosulfate administration is the first-line treatment for calciphylaxis, intralesional administration seems to be a reasonable alternative for injectable small lesions, even in recurrent cases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Calciphylaxis is a rare and life-threatening disorder characterized by painful skin ulceration. Intravenous sodium thiosulfate has proven effective for calciphylaxis treatment; however, its use is associated with risk of complications, potentially necessitating hospitalization. Herein, we describe the case of a patient with calciphylaxis who experienced recurrence approximately 5 months after healing with a combination therapy of intralesional/intravenous sodium thiosulfate. We successfully treated the recurrent ulcers in outpatient care with intralesional sodium thiosulfate, which reportedly has few side effects. Although intravenous sodium thiosulfate administration is the first-line treatment for calciphylaxis, intralesional administration seems to be a reasonable alternative for injectable small lesions, even in recurrent cases.
Key concepts: Calciphylaxis, Sodium thiosulfate, Medicine, Thiosulfate, Surgery, Wound care, Internal medicine, Chemistry